Article
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.
Frontiers in endocrinology - 1 Jan 2022
Mellid Sara, Gil Eduardo, Letón Rocío, Caleiras Eduardo, Honrado Emiliano, Richter Susan, Palacios Nuria, Lahera Marcos, Galofré Juan C, López-Fernández Adriá, Calatayud Maria, Herrera-Martínez Aura D, Galvez María A, Matias-Guiu Xavier, Balbín Milagros, Korpershoek Esther, Lim Eugénie S, Maletta Francesca, Lider Sofia, Fliedner Stephanie M J, Bechmann Nicole, Eisenhofer Graeme, Canu Letizia, Rapizzi Elena, Bancos Irina, Robledo Mercedes, Cascón Alberto
Abstract excerpt
Introduction: The percentage of patients diagnosed with pheochromocytoma and paraganglioma (altogether PPGL) carrying known germline mutations in one of the over fifteen susceptibility genes identified to date has dramatically increased during the last two decades, accounting for up to 35-40% of PPGL patients. Moreover, the application of NGS to the diagnosis of PPGL detects unexpected co-occurrences of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
